Source: BioPortfolio

Formula Pharmaceuticals: Formula Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryFormula Pharmaceuticals Inc Formula Pharmaceuticals is a biopharmaceutical company that concentrates on the development of chimeric antigen receptor CAR immunotherapy for oncology and autoimmune diseases. The company's portfolio of pipeline products...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Maurits W. Geerlings's photo - President & CEO of Formula Pharmaceuticals

President & CEO

Maurits W. Geerlings

CEO Approval Rating

70/100

Read more